Clinical Trial Update: Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study evaluating safety, tolerability and pharmacokinetics of IC14 in motor neuron disease/ALS; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Drugs mentioned

• IC14

Snippet

Sponsor: Implicit Bioscience | Conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED